TIRmed Pharma´s product candidate is a chemically stabilized, single-stranded oligonucleotide, which has non-coding and non-complementary sequence. The compound is formulated in a cream aiming for a self-applied and easy to use at-home anti-itch treatment. The product through its mode-of-action, which saves vital immune defenses and has anti-itch effects, would have potential for safe and effective treatment of mild to moderate atopic dermatitis. Atopic dermatitis is associated with a disrupted skin barrier facilitating entry of external allergens and compounds for treatment. Topical delivery to the skin limits systemic adverse events. TIRmed´s cream is intended for early mild-moderate symptoms to limit the use of biologicals.
Company Details
- Employees
- 6
- Founded
- 2018
- Address
- Alviksvägen, Stockholm,stockholm County 167 53,sweden
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.tirmedpharma.com/
- Keywords
- Birmingham.
- HQ
- Stockholm, Stockholm County
Tirmed Pharma Questions
Tirmed Pharma's website is https://www.tirmedpharma.com/
Tirmed Pharma's LinkedIn profile is https://se.linkedin.com/company/tirmed-pharma
Tirmed Pharma has
6 employees.
View email and phone details for 6
employees at Tirmed Pharma.
Tirmed Pharma's industry is
Pharmaceutical Manufacturing
Tirmed Pharma's top competitors are
Healthcap,
Chosa Oncology,
Cereno Scientific,
Mycural Therapeutics,
Peptisystems Ab,
Sciety,
Lumien,
Perimed Ab,
Umecrine Cognition Ab,
Akiram Therapeutics.
Tirmed Pharma's categories are Pharmaceutical Manufacturing
Tirmed Pharma's founding year is 2018
